{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PTCT/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:26:06.338Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":117,"canonical_name":"PTC THERAPEUTICS, INC.","cik":"0001070081","uei":null,"lei":null,"duns":null,"ticker":"PTCT"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":160,"clinical":4},"count":100,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-10-13","url_slug":"/sec/cik-0001070081/4/0001578852-26-000026","accession_number":"0001578852-26-000026","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-10-09","url_slug":"/sec/cik-0001070081/144/0001959173-26-007327","accession_number":"0001959173-26-007327","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-10-09","url_slug":"/sec/cik-0001070081/4/0001288952-26-000014","accession_number":"0001288952-26-000014","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-10-07","url_slug":"/sec/cik-0001070081/144/0001628280-26-065336","accession_number":"0001628280-26-065336","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-10-07","url_slug":"/sec/cik-0001070081/4/0001578852-26-000024","accession_number":"0001578852-26-000024","importance":30},{"ts":"2026-10-06","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-10-06","url_slug":"/sec/cik-0001070081/144/0001959173-26-007297","accession_number":"0001959173-26-007297","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-10-05","url_slug":"/sec/cik-0001070081/144/0001959173-26-007274","accession_number":"0001959173-26-007274","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-10-02","url_slug":"/sec/cik-0001070081/4/0001269131-26-000005","accession_number":"0001269131-26-000005","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-09-30","url_slug":"/sec/cik-0001070081/144/0001959173-26-007148","accession_number":"0001959173-26-007148","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-09-21","url_slug":"/sec/cik-0001070081/8-k/0001070081-26-000023","accession_number":"0001070081-26-000023","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-09-18","url_slug":"/sec/cik-0001070081/4/0001288952-26-000012","accession_number":"0001288952-26-000012","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-09-11","url_slug":"/sec/cik-0001070081/4/0001288952-26-000008","accession_number":"0001288952-26-000008","importance":30},{"ts":"2026-09-10","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":10000,"price_per_share":67.34,"usd_value":673400,"security_title":"Common Stock","importance":35.6734},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":9428,"price_per_share":67.79,"usd_value":639124,"security_title":"Common Stock","importance":35.63912412},{"ts":"2026-09-09","kind":"sec.insider.s","reporter":"SCHMERTZLER MICHAEL","title":"","shares":572,"price_per_share":68.67,"usd_value":39279,"security_title":"Common Stock","importance":35.03927924},{"ts":"2026-09-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-09-09","url_slug":"/sec/cik-0001070081/144/0001628280-26-061154","accession_number":"0001628280-26-061154","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-08-28","url_slug":"/sec/cik-0001070081/8-k/0001070081-26-000019","accession_number":"0001070081-26-000019","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-08-28","url_slug":"/sec/cik-0001070081/4/0001288952-26-000006","accession_number":"0001288952-26-000006","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"144/A","title":"144/A — PTC THERAPEUTICS, INC. — 2026-08-25","url_slug":"/sec/cik-0001070081/144-a/0001628280-26-058901","accession_number":"0001628280-26-058901","importance":30},{"ts":"2026-08-21","kind":"clinical.trial","reporter":"PTC Therapeutics","title":"Study of PTC844 in Participants With Active Rheumatoid Arthritis","security_title":"PHASE2","status":"NOT_YET_RECRUITING","accession_number":"NCT07779616","excerpt":"[\"Rheumatoid Arthritis\"]","importance":45},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-08-21","url_slug":"/sec/cik-0001070081/4/0001288952-26-000004","accession_number":"0001288952-26-000004","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-08-19","url_slug":"/sec/cik-0001070081/144/0001628280-26-058006","accession_number":"0001628280-26-058006","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-08-19","url_slug":"/sec/cik-0001070081/4/0001578852-26-000022","accession_number":"0001578852-26-000022","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-08-17","url_slug":"/sec/cik-0001070081/144/0001959173-26-006063","accession_number":"0001959173-26-006063","importance":30},{"ts":"2026-08-14","kind":"clinical.trial","reporter":"PTC Therapeutics","title":"Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07681713","excerpt":"[\"Friedreich's Ataxia\"]","importance":60},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-08-13","url_slug":"/sec/cik-0001070081/8-k/0001104659-26-095424","accession_number":"0001104659-26-095424","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-08-06","url_slug":"/sec/cik-0001070081/4/0001808968-26-000017","accession_number":"0001808968-26-000017","importance":30},{"ts":"2026-08-04","kind":"sec.insider.s","reporter":"Klein Matthew B.","title":"CHIEF EXECUTIVE OFFICER","shares":10292,"price_per_share":68.57,"usd_value":705722,"security_title":"Common Stock","importance":35.70572244},{"ts":"2026-08-04","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-08-04","url_slug":"/sec/cik-0001070081/144/0001959173-26-005607","accession_number":"0001959173-26-005607","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"10-Q","title":"10-Q — PTC THERAPEUTICS, INC. — 2026-07-30","url_slug":"/sec/cik-0001070081/10-q/0001070081-26-000017","accession_number":"0001070081-26-000017","importance":45},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — PTC THERAPEUTICS, INC. — 2026-07-30","url_slug":"/sec/cik-0001070081/8-k/0001070081-26-000016","accession_number":"0001070081-26-000016","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"3","title":"3 — PTC THERAPEUTICS, INC. — 2026-07-30","url_slug":"/sec/cik-0001070081/3/0002142653-26-000003","accession_number":"0002142653-26-000003","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-30","url_slug":"/sec/cik-0001070081/4/0002142653-26-000004","accession_number":"0002142653-26-000004","importance":30},{"ts":"2026-07-28","kind":"sec.insider.a","reporter":"Sollie-Zetlmayer Hege Elisabeth","title":"","shares":4000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-28","kind":"sec.insider.a","reporter":"Sollie-Zetlmayer Hege Elisabeth","title":"","shares":2000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-16","url_slug":"/sec/cik-0001070081/4/0001984065-26-000008","accession_number":"0001984065-26-000008","importance":30},{"ts":"2026-07-14","kind":"sec.form144","reporter":"Gravier Pierre","title":"Officer","shares":3494,"usd_value":280733,"security_title":"Common","approx_sale_date":"2026-07-14","accession_number":"0001959173-26-005220","importance":40.056146554},{"ts":"2026-07-14","kind":"sec.insider.s","reporter":"Gravier Pierre","title":"CHIEF FINANCIAL OFFICER","shares":3494,"price_per_share":80.35,"usd_value":280743,"security_title":"Common Stock","importance":35.2807429},{"ts":"2026-07-14","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-14","url_slug":"/sec/cik-0001070081/144/0001959173-26-005220","accession_number":"0001959173-26-005220","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-13","url_slug":"/sec/cik-0001070081/4/0001578850-26-000023","accession_number":"0001578850-26-000023","importance":30},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-13","url_slug":"/sec/cik-0001070081/4/0001866044-26-000005","accession_number":"0001866044-26-000005","importance":30},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Smith Mary L.","title":"Director","shares":15834,"usd_value":1425060,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001959173-26-005172","importance":40.285012},{"ts":"2026-07-09","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":2464,"usd_value":222368,"security_title":"Common","approx_sale_date":"2026-07-09","accession_number":"0001959173-26-005179","importance":40.044473646},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Smith Mary L.","title":"","shares":10000,"price_per_share":90,"usd_value":900000,"security_title":"Common Stock","importance":35.9},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Smith Mary L.","title":"","shares":5834,"price_per_share":90,"usd_value":525060,"security_title":"Common Stock","importance":35.52506},{"ts":"2026-07-09","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2464,"price_per_share":90.25,"usd_value":222376,"security_title":"Common Stock","importance":35.222376},{"ts":"2026-07-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-09","url_slug":"/sec/cik-0001070081/144/0001959173-26-005172","accession_number":"0001959173-26-005172","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-09","url_slug":"/sec/cik-0001070081/144/0001959173-26-005179","accession_number":"0001959173-26-005179","importance":30},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Smith Mary L.","title":"","shares":10000,"price_per_share":42.95,"usd_value":429500,"security_title":"Common Stock","importance":15.4295},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Smith Mary L.","title":"","shares":5834,"price_per_share":42.95,"usd_value":250570,"security_title":"Common Stock","importance":15.2505703},{"ts":"2026-07-09","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2464,"price_per_share":46.54,"usd_value":114675,"security_title":"Common Stock","importance":15.11467456},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-08","url_slug":"/sec/cik-0001070081/4/0001578852-26-000020","accession_number":"0001578852-26-000020","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-07-08","url_slug":"/sec/cik-0001070081/4/0001578850-26-000021","accession_number":"0001578850-26-000021","importance":30},{"ts":"2026-07-07","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":24613,"usd_value":2187696,"security_title":"Common","approx_sale_date":"2026-07-07","accession_number":"0001959173-26-005150","importance":40.437539122},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":11369,"price_per_share":89.03,"usd_value":1012182,"security_title":"Common Stock","importance":36.01218207},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":9288,"price_per_share":89.44,"usd_value":830719,"security_title":"Common Stock","importance":35.83071872},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":3956,"price_per_share":87.17,"usd_value":344845,"security_title":"Common Stock","importance":35.34484452},{"ts":"2026-07-07","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-07","url_slug":"/sec/cik-0001070081/144/0001959173-26-005150","accession_number":"0001959173-26-005150","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":24613,"price_per_share":39.42,"usd_value":970244,"security_title":"Common Stock","importance":15.97024446},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":22161,"usd_value":1905797,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005117","importance":40.381159486},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Boulding Mark Elliott","title":"Officer","shares":5079,"usd_value":427322,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001959173-26-005114","importance":40.085464334},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":10090,"price_per_share":86.32,"usd_value":870969,"security_title":"Common Stock","importance":35.8709688},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":8786,"price_per_share":85.35,"usd_value":749885,"security_title":"Common Stock","importance":35.7498851},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2474,"price_per_share":87.03,"usd_value":215312,"security_title":"Common Stock","importance":35.21531222},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":1036,"price_per_share":84.41,"usd_value":87449,"security_title":"Common Stock","importance":35.08744876},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":833,"price_per_share":84.41,"usd_value":70314,"security_title":"Common Stock","importance":35.07031353},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":745,"price_per_share":86.38,"usd_value":64353,"security_title":"Common Stock","importance":35.0643531},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":645,"price_per_share":85.84,"usd_value":55367,"security_title":"Common Stock","importance":35.0553668},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":601,"price_per_share":86.38,"usd_value":51914,"security_title":"Common Stock","importance":35.05191438},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":519,"price_per_share":85.84,"usd_value":44551,"security_title":"Common Stock","importance":35.04455096},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":426,"price_per_share":85.28,"usd_value":36329,"security_title":"Common Stock","importance":35.03632928},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":385,"price_per_share":86.34,"usd_value":33241,"security_title":"Common Stock","importance":35.0332409},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":387,"price_per_share":83.1,"usd_value":32160,"security_title":"Common Stock","importance":35.0321597},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":313,"price_per_share":83.1,"usd_value":26010,"security_title":"Common Stock","importance":35.0260103},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-06","url_slug":"/sec/cik-0001070081/144/0001959173-26-005114","accession_number":"0001959173-26-005114","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-07-06","url_slug":"/sec/cik-0001070081/144/0001959173-26-005117","accession_number":"0001959173-26-005117","importance":30},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":18876,"price_per_share":38.1,"usd_value":719176,"security_title":"Common Stock","importance":15.7191756},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":2813,"price_per_share":46.54,"usd_value":130917,"security_title":"Common Stock","importance":15.13091702},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":2474,"price_per_share":39.42,"usd_value":97525,"security_title":"Common Stock","importance":15.09752508},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Boulding Mark Elliott","title":"EXEC. VP AND CLO","shares":2266,"price_per_share":39.42,"usd_value":89326,"security_title":"Common Stock","importance":15.08932572},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":811,"price_per_share":38.1,"usd_value":30899,"security_title":"Common Stock","importance":15.0308991},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-30","url_slug":"/sec/cik-0001070081/4/0001578850-26-000019","accession_number":"0001578850-26-000019","importance":30},{"ts":"2026-06-26","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":8130,"usd_value":693146,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001959173-26-004919","importance":40.13862921},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":7718,"price_per_share":85.26,"usd_value":658037,"security_title":"Common Stock","importance":35.65803668},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":412,"price_per_share":85.23,"usd_value":35115,"security_title":"Common Stock","importance":35.03511476},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-26","url_slug":"/sec/cik-0001070081/144/0001959173-26-004919","accession_number":"0001959173-26-004919","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — PTC THERAPEUTICS, INC. — 2026-06-26","url_slug":"/sec/cik-0001070081/4/0001578850-26-000017","accession_number":"0001578850-26-000017","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":7718,"price_per_share":38.1,"usd_value":294056,"security_title":"Common Stock","importance":15.2940558},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":412,"price_per_share":38.1,"usd_value":15697,"security_title":"Common Stock","importance":15.0156972},{"ts":"2026-06-25","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":20960,"usd_value":1801869,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001959173-26-004899","importance":40.36037388},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":11337,"price_per_share":86.51,"usd_value":980764,"security_title":"Common Stock","importance":35.98076387},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":8522,"price_per_share":85.26,"usd_value":726586,"security_title":"Common Stock","importance":35.72658572},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":582,"price_per_share":85.24,"usd_value":49610,"security_title":"Common Stock","importance":35.04960968},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":419,"price_per_share":86.39,"usd_value":36197,"security_title":"Common Stock","importance":35.03619741},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":100,"price_per_share":87,"usd_value":8700,"security_title":"Common Stock","importance":35.0087},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — PTC THERAPEUTICS, INC. — 2026-06-25","url_slug":"/sec/cik-0001070081/144/0001959173-26-004899","accession_number":"0001959173-26-004899","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":19859,"price_per_share":38.1,"usd_value":756628,"security_title":"Common Stock","importance":15.7566279},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":1001,"price_per_share":38.1,"usd_value":38138,"security_title":"Common Stock","importance":15.0381381},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Almstead Neil Gregory","title":"CHIEF TECHNICAL OPS OFFICER","shares":100,"price_per_share":39.42,"usd_value":3942,"security_title":"Common Stock","importance":15.003942},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Almstead Neil Gregory","title":"Officer","shares":5323,"usd_value":452592,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001959173-26-004862","importance":40.090518316}]}